The Mesothelioma Center News – Page 4

• 

  Research & Clinical Trials

  Gene Therapy Clinical Trial for Mesothelioma Moving Forward

  A much-anticipated, phase III clinical trial studying the use of gene therapy to combat pleural mesothelioma cancer has made a promising start. Interest…

  

  Tim Povtak

  September 23, 2020
• 

  Research & Clinical Trials

  Mesothelioma Trial to Test Cancer Vaccine with Immunotherapy

  A research team at Oslo University Hospital in Norway has opened a mesothelioma clinical trial using the novel UV1 cancer vaccine alongside a…

  

  Tim Povtak

  September 14, 2020
• 

  Asbestos Exposure & Bans

  Peer Review Finds EPA’s Asbestos Risk Evaluation Flawed

  The Science Advisory Committee on Chemicals found considerable failings and an underestimation of danger to the general public in a draft risk evaluation of…

  

  Tim Povtak

  September 2, 2020
• 

  Asbestos Exposure & Bans

  Georgia-Pacific Pledges $1B to Bestwall Asbestos Trust Fund

  Georgia-Pacific has pledged $1 billion to fund an asbestos trust for bankrupt affiliate Bestwall LLC, clearing the path to a settlement of longstanding liability…

  

  Tim Povtak

  August 25, 2020
• 

  Research & Clinical Trials

  New Lung Cancer Trial Could Benefit Mesothelioma Patients

  Pharmaceutical giant Merck has teamed up with Novocure to test its cornerstone immunotherapy, pembrolizumab (Keytruda), alongside Tumor Treating Fields. The new phase II…

  

  Sean Marchese, MS, RN

  August 19, 2020
• 

  Research & Clinical Trials

  Immunotherapy Combination Extends Mesothelioma Survival

  Standard-of-care treatment for unresectable pleural mesothelioma cancer could be changing soon, sparked by a recently completed international study of a novel immunotherapy combination.

  

  Tim Povtak

  August 11, 2020
• 

  Research & Clinical Trials

  Mesothelioma Clinical Trials Resume After COVID-19 Disruption

  When the COVID-19 pandemic struck earlier this year, clinical trials at medical centers around the world slowed enrollment or placed trial activities on hold.

  

  Sean Marchese, MS, RN

  August 10, 2020
• 

  Research & Clinical Trials

  Mesothelioma T-Cell Therapy Shows Early Effectiveness in Trial

  A mesothelioma clinical trial involving genetically modified T cells has opened to considerable acclaim, shrinking tumors in the first five patients who were treated.

  

  Tim Povtak

  August 4, 2020
• 

  Treatment & Doctors

  Mesothelioma Specialty Centers Rank on 2020 Best Hospitals List

  For the sixth consecutive year, University of Texas MD Anderson Cancer Center in Houston was named the top Adult Cancer Hospital in America…

  

  Tim Povtak

  July 29, 2020
• 

  Research & Clinical Trials

  Study Shows Peritoneal Mesothelioma Surgery Underutilized

  The continued underutilization of aggressive surgery for peritoneal mesothelioma is shortening survival time dramatically for patients who could qualify for, and benefit from,…

  

  Tim Povtak

  July 28, 2020